


Vaginal dryness after cancer treatment can cause burning, irritation and pain during intercourse. It can affect younger women too, and its severity depends partly on the treatment received and ovarian function. You can seek help both during cancer treatment and after it has finished.
At Tartaczna 2 Medical Centre in Gdańsk, consultations are provided by Dr Marek Korożan and Dr Volha Khitrun. Care is tailored to your symptoms, tissue health and your oncologist's recommendations.
Symptoms may result from reduced oestrogen effects on the tissues or direct tissue damage during treatment. Different treatments can have different consequences.
Some symptoms improve after treatment; others need ongoing care. Persistent symptoms are a reason to seek support.
Infections and vulval skin conditions can cause similar symptoms. Medical assessment helps establish the cause; burning alone does not confirm infection or tissue atrophy.

Bring your oncology records and a list of medicines. Relevant details include the cancer type, whether it was hormone-sensitive, previous operations, the area treated with radiotherapy and any current treatment.
Your gynaecologist examines the vulval skin and vaginal lining, adapting the examination to pain and treatment-related changes. Further investigations may be needed, for example to check for infection or assess a lesion that requires a biopsy.
For women with a history of hormone-sensitive cancer, care usually starts with nonhormonal options. These include regularly used vaginal moisturisers, such as products containing hyaluronic acid, and lubricants used during sexual activity. The product and application schedule depend on your symptoms and tolerance.
Avoiding irritating products and vaginal douching, and using gentle vulval skin care, may also help. Pelvic health physiotherapy may be appropriate for pain associated with muscle tension. After radiotherapy, if vaginal narrowing is a concern, your doctor may advise gradual use of vaginal dilators and explain when and how to start safely.
There is no single answer for everyone. The cancer type, risk of recurrence and current treatment matter. Local vaginal treatment requires a different assessment from systemic menopausal hormone therapy.
After hormone-sensitive breast cancer, low-dose vaginal oestrogen may be considered in selected circumstances when nonhormonal options have not provided enough relief, following discussion of the benefits and risks. In particular, women taking aromatase inhibitors should make this decision together with their gynaecologist and oncologist.
Do not stop cancer treatment or start hormonal treatment without medical advice.
Hyaluronic acid moisturisers and hyaluronic acid injections are different treatments. Evidence about creams or vaginal pessaries cannot automatically be applied to injections.
Laser treatment and procedures described as regenerative require careful assessment. They are not routine first-line treatments after cancer. A sham-controlled trial in breast cancer survivors taking aromatase inhibitors found no advantage of CO2 laser for the outcomes assessed at six months. Before considering a procedure, discuss the limitations of the evidence and possible risks, including pain, tissue injury and scarring.
Bleeding after menopause, repeated bleeding after intercourse, an ulcer, a new lump or increasing pain needs medical assessment. These symptoms should not automatically be attributed to dryness. Fever and significant symptoms during active cancer treatment require prompt contact with your oncology team.
Book a consultation with Dr Marek Korożan or Dr Volha Khitrun. Where needed, care for intimate symptoms is coordinated with your oncologist. An oncology consultation with Dr Magdalena Korożan is also available at our centre.
Contact the Tartaczna 2 Medical Centre reception team or book through ZnanyLekarz. Call +48 58 719 10 25 or email kontakt@tartaczna2.pl.